Cellebrite DI Ltd.
CLBT
$19.43
-$0.13-0.67%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 20.12% | 15.72% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 20.12% | 15.72% | |
| Cost of Revenue | -- | -- | 4.90% | -0.99% | |
| Gross Profit | -- | -- | 23.63% | 19.70% | |
| SG&A Expenses | -- | -- | 11.58% | 5.20% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 8.26% | 3.47% | |
| Operating Income | -- | -- | 3,083.62% | 745.51% | |
| Income Before Tax | -- | -- | -162.57% | -132.64% | |
| Income Tax Expenses | -- | -- | 12,404.44% | 2,905.14% | |
| Earnings from Continuing Operations | -- | -- | -167.13% | -135.85% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -167.13% | -135.85% | |
| EBIT | -- | -- | 3,083.62% | 745.51% | |
| EBITDA | -- | -- | 302.91% | 824.14% | |
| EPS Basic | -- | -- | -169.54% | -138.55% | |
| Normalized Basic EPS | -- | -- | -200.28% | -124.48% | |
| EPS Diluted | -- | -- | -177.87% | -143.08% | |
| Normalized Diluted EPS | -- | -- | -205.65% | -127.06% | |
| Average Basic Shares Outstanding | -- | -- | 4.08% | 3.46% | |
| Average Diluted Shares Outstanding | -- | -- | -0.12% | -1.14% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |